HOME >> BIOLOGY >> NEWS
Synchrotron could help save the Tassie devil

Australias new $200m synchrotron in Melbourne could contribute to the fight to save the Tasmanian devil from the outbreak of facial tumour disease currently decimating devil populations, according to Dr Jeff Church from CSIRO Textile and Fibre Technology in Geelong.

Dr Church says he will use the synchrotron to see if the disease causes any biochemical changes in the devils which could be detected in their hair before the disease becomes apparent.

If we find a consistent change, it could lead to the development of a test which will allow detection of the cancer before the tumours become evident, he says. This would make any quarantine strategy easier to establish, as well as much more efficient.

The idea is based on Australian research showing disease-related changes in the composition of human hair. The suggestion is that similar changes could occur in Tasmanian devils hair when the facial tumour disease is triggered. But, the theory needs to be fully tested, Dr Church says. It might work or it might not.

The synchrotrons infra-red beamline combined with a microscope and spectrometer which detects how different materials absorb and reflect the radiation can be used to determine if the composition of hair differs between diseased animals and healthy ones.

The infra-red spectrum tells us about protein and fat structure and whether its changing, Dr Church says. But the technology to do such work using a synchrotron is comparatively new, and the Australian facility is one of relatively few around the world where it is available.

If a diagnostic test for the facial tumour disease using the synchrotron does look possible, only having a machine nearby would make it viable. Having to queue-up for time on a synchrotron at least nine hours flying time from Tasmania more likely further would make the whole thing very difficult, particularly in terms of biosecurity concerns because we would need to transport
'"/>

Contact: Heather Forward
heather.forward@csiro.au
61-352-464-085
CSIRO Australia
1-Aug-2007


Page: 1 2

Related biology news :

1. Newly created cancer stem cells could aid breast cancer research
2. New system of wastewater treatment could reduce the size of treatment plants by half
3. Discovery of new protein could provide new understanding of male fertility
4. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
5. How a pain in the neck could be bad for your blood pressure
6. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
7. Fish eyes could hold clue to repairing damaged retinas in humans
8. New aerogels could clean contaminated water, purify hydrogen for fuel cells
9. MIT model could predict cells response to drugs
10. System to analyze beating heart stem cells could lead to heart attack treatments
11. Gene expression pattern could lead to improved treatment of pediatric septic shock

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Synchrotron could help save the Tassie devil

(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
(Date:5/23/2013)... Some prostate cancer patients unnecessarily undergo surgery or ... differences between slow-growing and aggressive forms of the ... Johns Hopkins Medical Institutes are developing technology that ... opt for relatively mild treatments or take drastic ... Anant Madabhushi, an associate professor of biomedical engineering ...
(Date:5/23/2013)... world are billions of animal and plant specimens from ... all stacked, stored and preserved in jars and collection ... critical to understanding how the Earth,s biodiversity is changing ... if only the information were easily accessible. , A ... of a team from the University of Colorado Boulder, ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
(Date:5/23/2013)... -- BioScrip, Inc. (NASDAQ: BIOS ) today announced ... Global Healthcare Conference to be held June 3-6, 2013 ... Richard Smith , President and Chief Executive ... Financial Officer, will present on Monday, June 3, 2013 ... About BioScrip BioScrip, Inc. provides comprehensive infusion and ...
(Date:5/23/2013)... , May 23, 2013  Rahal Letterman Lanigan Racing ... cord blood stem cell banking and therapeutics, announced today ... No. 16 Acorn Stairlifts Indy car driven by ... remainder of the IZOD IndyCar 2013 season.   ... work to support awareness of umbilical cord blood banking ...
(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor.   ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...
(Date:5/23/2013)... May 23, 2013 The New Jersey ... industries, Black Data Processing Associates (BDPA), is hosting its ... 8, 2013. This all-day event will encourage students and ... the ins and outs from many of the industries’ ... at the New Jersey Institute of Technology, the event ...
Breaking Biology Technology:StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2
Cached News: